Senticell

Next-generation diagnostic platform that uses red blood cell-captured tumor and pathogen DNA to detect disease at its earliest stage.

Confirmed by founder

Founded 2022

HealthcareMedical DevicesAIBiotechHealthTech

Capital FactoryAll Access Fund 2026

🟢 Raising Seed completed and oversubscribed, Series A - open — $20.0M target

AboutConfirmed by founder

Revolutionizing liquid biopsy through Red Blood Cell (RBC) substrate. Senticell is the next-generation diagnostic platform that uses Red Blood Cell-capture tumor and pathogen DNA to detect disease at its earliest stage.

Team

See something off about this company?